Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates

FHS
June 23, 2023
10:42 am

A new robotics platform was inaugurated at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) on Thursday, June 15, 2023, in the presence of Thuringia’s State Secretary for Research, Innovation and Economic Development.

Naloxone use by non-medical bystanders on the rise, but not fast enough

Use of a lifesaving drug to reverse opioid drug overdoses is growing, but not fast enough. That’s according to new research in JAMA Network Open

October 14, 2024

What Super-Agers Show; Epstein-Barr and Early MS; Five Variants of Alzheimer’s

Super-agers like Norman Lear, who died last month at age 101, show what successful cognitive aging looks like. A study at the Albert Einstein College

January 10, 2024

Alzheimer’s Diagnosis Takes More Than Biomarkers, Working Group Says

A definition of Alzheimer’s disease — one that requires objective cognitive deficits in addition to brain amyloid for Alzheimer’s to be diagnosed — was proposed

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.